Denosumab bests zoledronic acid for bone metastases

Commentary

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)42
Number of pages1
JournalOncology Report
Issue numberJANUARY-FEBRUARY
StatePublished - 2010

Fingerprint

zoledronic acid
Neoplasm Metastasis
Bone and Bones
Denosumab

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Denosumab bests zoledronic acid for bone metastases : Commentary. / Loprinzi, Charles Lawrence.

In: Oncology Report, No. JANUARY-FEBRUARY, 2010, p. 42.

Research output: Contribution to journalArticle

@article{3264d01d1674402eafd8088398c3430d,
title = "Denosumab bests zoledronic acid for bone metastases: Commentary",
author = "Loprinzi, {Charles Lawrence}",
year = "2010",
language = "English (US)",
pages = "42",
journal = "Oncology Report",
issn = "1548-5323",
publisher = "Elsevier BV",
number = "JANUARY-FEBRUARY",

}

TY - JOUR

T1 - Denosumab bests zoledronic acid for bone metastases

T2 - Commentary

AU - Loprinzi, Charles Lawrence

PY - 2010

Y1 - 2010

UR - http://www.scopus.com/inward/record.url?scp=77749267759&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77749267759&partnerID=8YFLogxK

M3 - Article

SP - 42

JO - Oncology Report

JF - Oncology Report

SN - 1548-5323

IS - JANUARY-FEBRUARY

ER -